{"nct_id":"NCT02674568","title":"Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2016-01-25","start_date_type":"ACTUAL","primary_completion_date":"2018-10-19","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-19","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}